National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 23601 [2024-07156]

Download as PDF Federal Register / Vol. 89, No. 66 / Thursday, April 4, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering (NACBIB). Date: May 15, 2024. Open: 09:00 a.m. to 12:30 p.m. Agenda: Report from the Institute Director, Council Members and other Institute Staff. Place: John Edward Porter Neuroscience Research Center, Building 35A, Room 620/ 630, 35 Convent Drive, Bethesda, Maryland 20892 (In-person Meeting). Closed: 1:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: John Edward Porter Neuroscience Research Center, Building 35A, Room 620/ 630, 35 Convent Drive, Bethesda, Maryland 20892 (In-person Meeting). Contact Person: David T. George, Ph.D., Associate Director for Research Administration, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Bethesda, MD 20892, georged@mail.nih.gov. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. In person attendees should register at (https://www.nibib.nih.gov/about-nibib/ advisory-council) in advance of the meeting so that the meeting organizers can plan accordingly. The meeting will be videocast and can be accessed from the NIH Videocasting website at (https://videocast.nih.gov/watch=54286). Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nibib.nih.gov/about-nibib/advisorycouncil where an agenda and any additional information for the meeting will be posted when available. VerDate Sep<11>2014 17:01 Apr 03, 2024 Jkt 262001 Dated: March 29, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2024–07112 Filed 4–3–24; 8:45 am] [Docket No. USCG–2024–0232] 23601 Coast Guard BILLING CODE 4140–01–P National Maritime Security Advisory Committee; May 2024 Virtual Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA–DK–22–028 Pilot and Feasibility Trials on the Integration of Social and Medical Care for T1D. Date: June 7, 2024. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Cheryl Nordstrom, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7013, 6707 Democracy Blvd., Bethesda, MD 20892–2542, 301–402–6711, cheryl.nordstrom@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: April 1, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–07156 Filed 4–3–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of open Federal advisory committee meeting. AGENCY: The National Maritime Security Advisory Committee (Committee) will conduct a virtual meeting to discuss a new Committee task to provide Comment on the U.S. Coast Guard’s Notice of Proposed Rulemaking on Cybersecurity in the Marine Transportation System. The virtual meeting will be open to the public. SUMMARY: DATES: Meeting: The Committee will meet virtually on Friday, May 10, 2024, from 1 p.m. until 3 p.m. Eastern Daylight Time (EDT). Please note that this meeting may close early if the Committee has completed its business. Comments and supporting documentation: To ensure your comments are received by Committee members before the meeting, submit your written comments no later than May 9, 2024. ADDRESSES: The meeting will be held virtually. To join the virtual meeting or to request special accommodations, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section no later than 1 p.m. EDT on May 9, 2024, to obtain the needed information. The number of virtual lines are limited and will be available on a first-come, first-served basis. Pre-registration information: Preregistration is required for attending virtual meeting. You must request attendance by contacting the individual listed in the FOR FURTHER INFORMATION CONTACT section of this notice. You will receive a response with attendance instructions. The National Maritime Security Advisory Committee is committed to ensuring all participants have equal access regardless of disability status. If you require reasonable accommodations due to a disability to fully participate, please email Mr. Ryan Owens at ryan.f.owens.uscg.mil or call (202) 302– 6565 as soon as possible. Instructions: You are free to submit comments at any time, including orally at the meetings as time permits, but if you want Committee members to review E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 89, Number 66 (Thursday, April 4, 2024)]
[Notices]
[Page 23601]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Diabetes 
and Digestive and Kidney Diseases Advisory Council.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA-DK-22-028 Pilot and 
Feasibility Trials on the Integration of Social and Medical Care for 
T1D.
    Date: June 7, 2024.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Cheryl Nordstrom, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7013, 6707 Democracy Blvd., Bethesda, MD 20892-2542, 301-402-
6711, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: April 1, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-07156 Filed 4-3-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.